For instance, Alvarez-Erviti et al. successfully used exosomes to deliver α-synuclein-targeting siRNA in a mouse model of Parkinson’s disease, reducing α-synuclein aggregates and ameliorating disease symptoms. This evidence concerns the gene SNCA and Parkinson disease.